Evidence map›Paper›PMID 26138260›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2015

Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.

Jorge Cerdá, Kathleen D Liu, Dinna N Cruz, Bertrand L Jaber, Jay L Koyner, Michael Heung, Mark D Okusa, Sarah Faubel, AKI Advisory Group of the American Society of Nephrology

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jorge CerdáDepartment of Medicine, Division of Nephrology, Albany Medical College, Albany, New York; cerdaj@mail.amc.edu cerda@nycap.rr.com.
Kathleen D LiuDivision of Nephrology, Department of Medicine University of California, San Francisco, San Francisco, California.
Dinna N CruzDepartment of Medicine, Division of Nephrology, University of California San Diego, San Diego, California;
Bertrand L JaberDepartment of Medicine, St. Elizabeth's Medical Center Tufts University School of Medicine, Boston, Massachussetts;
Jay L KoynerDepartment of Nephrology, University of Chicago, Chicago, Illinois;
Michael HeungDepartment of Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan;
Mark D OkusaDepartment of Medicine, University of Virginia, Charlottesville, Virginia; and.
Sarah FaubelDepartment of Medicine, Division of Nephrology, University of Colorado Denver, Denver, Colorado.
AKI Advisory Group of the American Society of Nephrology

Funding

Leukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4M
NIDDK NIH HHS R01 DK062324
6 · The paper itself

Abstract

AKI requiring RRT is associated with high mortality, morbidity, and long-term consequences, including CKD and ESRD. Many patients never recover kidney function; in others, kidney function improves over a period of many weeks or months. Methodologic constraints of the available literature limit our understanding of the recovery process and hamper adequate intervention. Current management strategies have focused on acute care and short-term mortality, but new data indicate that long-term consequences of AKI requiring RRT are substantial. Promotion of kidney function recovery is a neglected focus of research and intervention. This lack of emphasis on recovery is illustrated by the relative paucity of research in this area and by the lack of demonstrated effective management strategies. In this article the epidemiologic implications of kidney recovery after AKI requiring RRT are discussed, the available literature and its methodologic constraints are reviewed, and strategies to improve the understanding of factors that affect kidney function recovery are proposed. Measures to promote kidney function recovery are a serious unmet need, with a great potential to improve short- and long-term patient outcomes.

Indexed as

Renal Replacement TherapyAcute Kidney InjuryAnticoagulantsHumansKidney Failure, ChronicRecovery of FunctionSurvival RateTime FactorsWater-Electrolyte BalanceAnticoagulantsAKIkidney function recoveryprogression of renal failureRRTsurvival

Identifiers

PMID26138260
PMCPMC4594060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.